OBJECTIVE: The purpose of this study was to investigate the potential benefits for medication adherence of integrating a patient-selected support person into an automated diabetes telemonitoring and self-management program, and to determine whether these benefits vary by patients' baseline level of psychological distress. STUDY DESIGN: The study was a quasi-experimental patient preference trial. METHODS: The study included patients with type 2 diabetes who participated in three to six months of weekly automated telemonitoring via interactive voice response (IVR) calls, with the option of designating a supportive relative or friend to receive automated updates on the patient's health and self-management, along with guidance regarding potential patient assistance. We measured long-term medication adherence using the four-point Morisky Medication Adherence Scale (MMAS-4, possible range 0-4), weekly adherence with an IVR item, and psychological distress at baseline with the Mental Composite Summary (MCS) of the SF-12. RESULTS: Of 98 initially nonadherent patients, 42% opted to involve a support person. Participants with a support person demonstrated significantly greater improvement in long-term adherence than those who participated alone (linear regression slopes: -1.17 vs. -0.57, respectively, p =0.001). Among distressed patients in particular, the odds of weekly nonadherence tended to decrease 25% per week for those with a support person (p =0.030), yet remained high for those who participated alone (p =0.820). CONCLUSIONS: Despite their multiple challenges in illness self-management, patients with diabetes who are both nonadherent and psychologically distressed may benefit by the incorporation of a support person when they receive assistance via automated telemonitoring.
OBJECTIVE: The purpose of this study was to investigate the potential benefits for medication adherence of integrating a patient-selected support person into an automated diabetes telemonitoring and self-management program, and to determine whether these benefits vary by patients' baseline level of psychological distress. STUDY DESIGN: The study was a quasi-experimental patient preference trial. METHODS: The study included patients with type 2 diabetes who participated in three to six months of weekly automated telemonitoring via interactive voice response (IVR) calls, with the option of designating a supportive relative or friend to receive automated updates on the patient's health and self-management, along with guidance regarding potential patient assistance. We measured long-term medication adherence using the four-point Morisky Medication Adherence Scale (MMAS-4, possible range 0-4), weekly adherence with an IVR item, and psychological distress at baseline with the Mental Composite Summary (MCS) of the SF-12. RESULTS: Of 98 initially nonadherent patients, 42% opted to involve a support person. Participants with a support person demonstrated significantly greater improvement in long-term adherence than those who participated alone (linear regression slopes: -1.17 vs. -0.57, respectively, p =0.001). Among distressed patients in particular, the odds of weekly nonadherence tended to decrease 25% per week for those with a support person (p =0.030), yet remained high for those who participated alone (p =0.820). CONCLUSIONS: Despite their multiple challenges in illness self-management, patients with diabetes who are both nonadherent and psychologically distressed may benefit by the incorporation of a support person when they receive assistance via automated telemonitoring.
Authors: Michael J Stirratt; Jacqueline Dunbar-Jacob; Heidi M Crane; Jane M Simoni; Susan Czajkowski; Marisa E Hilliard; James E Aikens; Christine M Hunter; Dawn I Velligan; Kristen Huntley; Gbenga Ogedegbe; Cynthia S Rand; Eleanor Schron; Wendy J Nilsen Journal: Transl Behav Med Date: 2015-07-09 Impact factor: 3.046
Authors: Tara W Strine; Kurt Kroenke; Satvinder Dhingra; Lina S Balluz; Olinda Gonzalez; Joyce T Berry; Ali H Mokdad Journal: J Nerv Ment Dis Date: 2009-01 Impact factor: 2.254
Authors: Lisa D Chew; Joan M Griffin; Melissa R Partin; Siamak Noorbaloochi; Joseph P Grill; Annamay Snyder; Katharine A Bradley; Sean M Nugent; Alisha D Baines; Michelle Vanryn Journal: J Gen Intern Med Date: 2008-03-12 Impact factor: 5.128
Authors: Robert M Anderson; Martha M Funnell; James E Aikens; Sarah L Krein; James T Fitzgerald; Robin Nwankwo; Cheryl L Tannas; Tricia S Tang Journal: Ther Patient Educ Date: 2009-06-01
Authors: Lesli E Skolarus; John D Piette; Paul N Pfeiffer; Linda S Williams; Jason Mackey; Rebecca Hughes; Lewis B Morgenstern Journal: Transl Stroke Res Date: 2016-07-09 Impact factor: 6.829
Authors: Panan Pichayapinyo; Laura R Saslow; James E Aikens; Nicolle Marinec; Jutatip Sillabutra; Piyamon Rattanapongsai; John D Piette Journal: Int J Nurs Pract Date: 2019-09-18 Impact factor: 2.066
Authors: John D Piette; Nicolle Marinec; Kathryn Janda; Emily Morgan; Karolina Schantz; Amparo Clara Aruquipa Yujra; Bismarck Pinto; José Marecelo Huayta Soto; Mary Janevic; James E Aikens Journal: Telemed J E Health Date: 2015-09-09 Impact factor: 3.536
Authors: John D Piette; Dana Striplin; Lawrence Fisher; James E Aikens; Aaron Lee; Nicolle Marinec; Madhura Mansabdar; Jenny Chen; Lynn A Gregory; Christopher S Kim Journal: Jt Comm J Qual Patient Saf Date: 2019-12-04